2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial.

Details for Australian Patent Application No. 2007248951 (hide)

International Classifications

Event Publications

13 November 2008 PCT application entered the National Phase

PCT publication WO2007/129963 Priority application(s): WO2007/129963

19 May 2011 Application Accepted

Published as AU-B-2007248951

15 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.